<DOC>
	<DOCNO>NCT00955162</DOCNO>
	<brief_summary>Patients admit use buprenorphine intravenous route randomize either Subutex Suboxone follow 3 month determine less injection Suboxone Subutex base primarily patient diary . Patients randomize Suboxone may continue receive product 9 month request monitor 3 month interval . Patients receive payment inconvenience keep daily diary cover travel expense .</brief_summary>
	<brief_title>Effectiveness Buprenorphine/Naloxone Reducing Intravenous Buprenorphine Misuse France ( `` RIME '' )</brief_title>
	<detailed_description />
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>1 . Male female opioiddependent outpatient age 18 year old , 2 . Women childbearing potential must negative urine pregnancy test result Inclusion Visit ( test supervision investigator designee ) , 3 . Women childbearing potential must use effective birth control method . Women nonchildbearing potential must postmenopausal must surgically sterile ( hysterectomy and/or bilateral oophorectomy ) , 4 . On buprenorphine ( Subutex® generic buprenorphine ) maintenance therapy minimum daily dose 2 mg least 3 month prior inclusion , 5 . Declaring buprenorphine intravenous misuse least four times/week show needle mark , 6 . Willing stop reduce buprenorphine intravenous misuse , 7 . Having receive oral write information trial , provide write informed consent prior admission trial . 1 . Pregnancy breastfeeding , 2 . Contraindication history hypersensitivity buprenorphine , naloxone excipient Suboxone® Subutex® , 3 . Any medical psychiatric condition opinion investigator would make participation difficult unsafe , 4 . Participating another trial , 5 . Patients exclusion period `` Fichier National de personnes qui se prêtent à de recherches biomédicales '' ( National Index person participate biomedical research , National Index volunteer ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Substance Abuse , Intravenous</keyword>
	<keyword>Buprenorphine</keyword>
</DOC>